LifeStance Therapists & Psychiatrists Spokane
221 North Wall Street, Suite 202, Spokane
4.6(176 Google reviews)
United States
5 listed treatment centers serving Spokane and the surrounding area.
221 North Wall Street, Suite 202, Spokane
4.6(176 Google reviews)
221 North Wall Street, Suite 202, Spokane
4.8(56 Google reviews)
731 North Stanley Street, Medical Lake
5.0(34 Google reviews)
765 East Holland Avenue, Spokane
The cost of Spravato treatment depends on your insurance benefits, the treatment setting, and your prescribed schedule. Ask about the full visit cost, not just the medication: the nasal spray and the supervised treatment and monitoring services may be billed separately. Your deductible, copayments, or coinsurance may apply differently to those charges.
Prior authorization is common. Your insurer may request records of earlier antidepressant trials, including which medications you took, how long you took them, and how you responded. Ask the treatment center who gathers these records and submits the request. If records are held by another prescriber, arranging their transfer before scheduling may help avoid delays.
Medicare coverage may fall under Part B or Part D depending on the plan and setting. Washington Medicaid may also cover treatment, but requirements and participating providers vary. Do not assume that a center accepts your coverage simply because it offers Spravato.
Manufacturer savings programs exist for eligible commercially insured patients, but not for people using government insurance. Eligibility rules and covered expenses vary; ask about current terms and any monitoring charges excluded from assistance.
Before starting, ask the center and your insurer:
Request a written estimate and benefit explanation before committing to appointments.
This directory currently lists no treatment center in Spokane. That does not establish that treatment is unavailable locally. Medical Lake appears in the supplied center summary and is a nearby place to check, but its REMS certification is not verified in this directory. Before making travel plans, confirm directly that a location is REMS-certified, currently provides Spravato, and is accepting new patients.
Spravato is never a take-home medication. You self-administer the nasal spray in a REMS-certified healthcare setting under direct observation. Monitoring lasts at least two hours after each dose, so allow additional time for check-in, preparation, and assessment before leaving. Some visits may require longer observation.
For treatment-resistant depression, the typical labeled schedule starts with twice-weekly visits during weeks 1–4, then weekly visits during weeks 5–8. Maintenance may be weekly or every two weeks. Your prescriber determines the schedule appropriate for you; do not assume your appointments will follow a fixed long-term pattern.
Arrange for someone else to drive you home after every visit. You must not drive or operate machinery until the next day after a restful sleep. Ask the center whether it has specific escort requirements before relying on a taxi or rideshare.
For practical planning:
If Spokane appointments are unavailable, ask about Medical Lake availability and confirm certification, insurance participation, and scheduling before traveling.
This directory currently lists no treatment center in Spokane. Medical Lake appears in the available center summary, but REMS certification is not verified here. Contact any prospective location to confirm that it is REMS-certified, offers Spravato, and accepts new patients. Your mental health prescriber can also help you explore referral options. A directory entry alone does not confirm certification or availability.
Spravato is FDA-approved for adults with treatment-resistant depression, alone or with an oral antidepressant. It is also approved, together with an oral antidepressant, for depressive symptoms in adults with major depressive disorder with acute suicidal ideation or behavior. It is not approved for children. A clinician must review your diagnosis, treatment history, and health risks to decide whether it is appropriate.
Coverage depends on your plan and the treatment setting. Prior authorization and documentation of previous antidepressant trials are common requirements. Medicare and Washington Medicaid may cover treatment in some circumstances, but coverage and provider participation must be checked individually. Ask about both medication and monitoring charges, network status, and your expected share of costs before scheduling.
You self-administer the nasal spray under a healthcare provider’s direct observation in a REMS-certified setting. The team monitors you for at least two hours afterward, including for sedation, dissociation, breathing problems, and blood pressure increases. Allow more than two hours for the complete appointment. Arrange a ride home, and do not drive until the next day after a restful sleep.
Important risks include sedation, dissociation—feeling disconnected from yourself or your surroundings—respiratory depression, and blood pressure increases. Spravato carries boxed warnings for sedation, dissociation, respiratory depression, abuse and misuse, and suicidal thoughts and behaviors. It is a Schedule III controlled substance. Discuss your health history, medications, and any substance-use concerns with your prescriber before treatment.
No. Spravato has not been demonstrated to prevent suicide or reduce suicidal thoughts or behavior, and it does not replace hospitalization when clinically needed. Although it has an approved use for depressive symptoms in certain adults with acute suicidal ideation or behavior, that is not a guarantee of safety. For immediate crisis support, call or text 988. If you are in immediate danger, call 911.
Approved uses, nearby treatment centers, and medically sourced patient guides.